المؤلفون: Jain, Akshay B., Reichert, Sonja M., Amadid, Hanan, Braae, Uffe C., Bradley, Ryan M., Kim, James W., Soo, Victoria, Yale, Jean‐François

المساهمون: Novo Nordisk Pharma

المصدر: Diabetes, Obesity and Metabolism ; volume 26, issue 5, page 1799-1807 ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.15493Test

المؤلفون: Suzuki, Ryo, Amadid, Hanan, Major‐Pedersen, Atheline, Yabe, Daisuke

المساهمون: Novo Nordisk

المصدر: Journal of Diabetes Investigation ; ISSN 2040-1116 2040-1124

الإتاحة: https://doi.org/10.1111/jdi.14219Test

المؤلفون: Kick, Anastas, M’Rabet-Bensalah, Khadija, Acquistapace, Flavio, Amadid, Hanan, Ambühl, Robert A., Braae, Uffe Christian, Item, Flurin, Schultes, Bernd, Züger, Thomas, Rudofsky, Gottfried

المساهمون: Novo Nordisk A/S

المصدر: Diabetes Therapy ; ISSN 1869-6953 1869-6961

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Internal Medicine

الإتاحة: https://doi.org/10.1007/s13300-023-01525-yTest

المؤلفون: Bain, Stephen C, Carstensen, Bendix, Hyveled, Liselotte, Seremetis, Stephanie, Flindt Kreiner, Frederik, Amadid, Hanan, Clark, Alice

المساهمون: Novo Nordisk A/S

المصدر: BMJ Open Diabetes Research & Care ; volume 11, issue 3, page e003300 ; ISSN 2052-4897

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism

الإتاحة: https://doi.org/10.1136/bmjdrc-2022-003300Test

المؤلفون: van Houtum, William, Schrömbges, Patrick, Amadid, Hanan, van Bon, Arianne C, Braae, Uffe C, Hoogstraten, Charlotte, Herrings, Hans

المصدر: Diabetes Ther ; ISSN:1869-6953

مصطلحات موضوعية: Body weight, GLP-1 receptor agonist, Glycaemic control, HbA1c, Incretin therapy, Real-world evidence, Semaglutide, Type 2 diabetes

العلاقة: https://doi.org/10.1007/s13300-024-01588-5Test; https://pubmed.ncbi.nlm.nih.gov/38861137Test

الإتاحة: https://doi.org/10.1007/s13300-024-01588-5Test
https://pubmed.ncbi.nlm.nih.gov/38861137Test

المؤلفون: Schmidt, Kirstine, Færch, Kristine, Zoffmann, Vibeke, Amadid, Hanan, Varming, Annemarie R.

المصدر: Schmidt , K , Færch , K , Zoffmann , V , Amadid , H & Varming , A R 2022 , ' The process of health behaviour change following participation in a randomised controlled trial targeting prediabetes : A qualitative study ' , Diabetic Medicine , vol. 39 , no. 4 , e14748 . https://doi.org/10.1111/dme.14748Test

مصطلحات موضوعية: behaviour, lifestyle, medication, overweight, prediabetes, randomised controlled trial

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1111/dme.14748Test
https://curis.ku.dk/portal/da/publications/the-process-of-health-behaviour-change-following-participation-in-a-randomised-controlled-trial-targeting-prediabetesTest(07800a79-6aa8-4a43-afbe-441553642c73).html
https://curis.ku.dk/ws/files/306285774/OLEJ_dme.14748.pdfTest

المؤلفون: Amadid, Hanan, Clemmensen, Kim Katrine Bjerring, Vistisen, Dorte, Persson, Frederik, Jørgensen, Marit Eika

المساهمون: Sanofi-Aventis Deutschland

المصدر: Cardiovascular Diabetology ; volume 21, issue 1 ; ISSN 1475-2840

مصطلحات موضوعية: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism

الإتاحة: https://doi.org/10.1186/s12933-022-01692-5Test

المؤلفون: Stougaard, Elisabeth B.¹ elisabeth.buur.stougaard@regionh.dk, Amadid, Hanan², Søndergaard, Esben³, Carstensen, Bendix², Jørgensen, Marit E.^2,4,5, Nørgaard, Kirsten^6,7, Rossing, Peter^1,7, Persson, Frederik¹, Vistisen, Dorte^2,8

المصدر: Diabetes Care. Nov2023, Vol. 46 Issue 11, p1897-1902. 6p.

المؤلفون: Mizrak, Hatice Isik, Hansen, Tine Willum, Rossing, Peter, Curovic, Viktor Rotbain, Vistisen, Dorte, Amadid, Hanan, Hansen, Christian Stevns

المصدر: Diabetes Care; Nov2023, Vol. 46 Issue 11, p1997-2003, 7p

المؤلفون: Amadid, Hanan, Rønn, Pernille F., Bekker-Nielsen Dunbar, Maria, Knudsen, Jakob S., Carstensen, Bendix, Persson, Frederik, Jørgensen, Marit E.

المصدر: Amadid , H , Rønn , P F , Bekker-Nielsen Dunbar , M , Knudsen , J S , Carstensen , B , Persson , F & Jørgensen , M E 2021 , ' A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population : A Danish nationwide cohort study ' , Diabetes, Obesity and Metabolism , vol. 23 , no. 10 , pp. 2354-2363 . https://doi.org/10.1111/dom.14478Test

مصطلحات موضوعية: atherosclerotic cardiovascular disease, dyslipidaemia, lipid-lowering drugs, pharmaco-epidemiology, type 2 diabetes

الإتاحة: https://doi.org/10.1111/dom.14478Test
https://pure.au.dk/portal/da/publications/a-large-remaining-potential-in-lipidlowering-drug-treatment-in-the-type-2-diabetes-populationTest(33b49a18-a899-4a3e-a9f7-dcb465cfe1c0).html
http://www.scopus.com/inward/record.url?scp=85111501008&partnerID=8YFLogxKTest